Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.05.2023 | Case report

Heparin

Type 2 heparin-induced thrombocytopenia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Asllanaj B, et al. Managing Acute Intermediate Risk Pulmonary Thromboembolism in a Patient Who Developed Heparin-Induced Thrombocytopenia: Review of Current Guidelines and Literature. Journal of Investigative Medicine High Impact Case Reports 11: 23247096231166673, Jan 2023. Available from: URL: http://doi.org/10.1177/23247096231166673 Asllanaj B, et al. Managing Acute Intermediate Risk Pulmonary Thromboembolism in a Patient Who Developed Heparin-Induced Thrombocytopenia: Review of Current Guidelines and Literature. Journal of Investigative Medicine High Impact Case Reports 11: 23247096231166673, Jan 2023. Available from: URL: http://​doi.​org/​10.​1177/​2324709623116667​3
Metadaten
Titel
Heparin
Type 2 heparin-induced thrombocytopenia: case report
Publikationsdatum
01.05.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-38433-4

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Antineoplastics

Case report

Posaconazole

Case report

Multiple drugs

Case report

Elasomeran

Case report

Pembrolizumab